MJT & Associates Financial Advisory Group »

Ionis Pharmaceuticals shares owned by MJT & Associates Financial Advisory Group

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by MJT & Associates Financial Advisory Group from 13F filings

Historical chart of MJT & Associates Financial Advisory Group investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by MJT & Associates Financial Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by MJT & Associates Financial Advisory Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2k 15 79.33

More positions owned by MJT & Associates Financial Advisory Group

Ishares Core S&p Total U.s. Com Market Etf Etf (ITOT)
Schwab Us Dividend Equity Etf Etf (SCHD)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares Ultra Short Duration Bond Active Etf Etf (ICSH)
Ishares 0-5 Year Tips Bond Etf Etf (STIP)
Wisdomtree U.s. Midcap Dividend Fund Etf (DON)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Ishares Core S&p Small Cap Etf Etf (IJR)
Jpmorgan Ultra-short Income Etf Etf (JPST)
Vanguard Mid-cap Growth Etf Etf (VOT)
Vanguard Mid-cap Value Etf Etf (VOE)
Ishares S&p 500 Value Etf Etf (IVE)
Vanguard Small Cap Value Etf Etf (VBR)
State Street Spdr Portfolio S&p 500 Etf Etf (SPYM)

View all positions for MJT & Associates Financial Advisory Group

Top funds holding Ionis Pharmaceuticals

FMR
Capital World Investors
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
Two Sigma Investments
State Street Corporation
Geode Capital Management
Royal Bank of Canada
T. Rowe Price Associates
Tweedy, Browne Company
Artisan Partners Limited Partnership
Baker Bros. Advisors
Deerfield Management Company

View all funds holding Ionis Pharmaceuticals